Peter Luo
Impact in
-
- Galectins and Cancer Biology
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 6
- Immunology 10
- Immunotherapy and Immune Responses 4
- Co-authors
- Guizhong Liu (13 shared papers)Louis Cohen (1 shared paper)Dominic A. Colosimo (1 shared paper)Amanda J. Pickard (1 shared paper)Justin R. Cross (1 shared paper)Sun M. Han (1 shared paper)Frank J. Piscotta (1 shared paper)Sean F. Brady (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)Developmental Biology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Peter Luo
20 papers receiving 334 citations
Peers
Comparison fields: 5 of 72
- Biological Psychiatry 19
- Immunology 76
- Molecular Biology 188
- Oncology 66
- Cell Biology 38
Countries citing papers authored by Peter Luo
This map shows the geographic impact of Peter Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Luo more than expected).
Fields of papers citing papers by Peter Luo
This network shows the impact of papers produced by Peter Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Luo. The network helps show where Peter Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 138 | |
| 2 | 2018 | 42 | |
| 3 | 2017 | 38 | |
| 4 | 2017 | 32 | |
| 5 | 2019 | 17 | |
| 6 | 2023 | 15 | |
| 7 | 2018 | 12 | |
| 8 | 2024 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2022 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2021 | 1 |
About Peter Luo
Peter Luo is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 344 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immunotherapy and Immune Responses (4 papers), Renal and related cancers (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Biological Psychiatry (19 citations), Immunology (76 citations), Molecular Biology (188 citations), Oncology (66 citations) and Cell Biology (38 citations). Peter Luo has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Guizhong Liu, Louis Cohen, Dominic A. Colosimo, Amanda J. Pickard, Justin R. Cross, Sun M. Han, Frank J. Piscotta, Sean F. Brady, Arka Rao and Michael Boyce. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Developmental Biology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.